Tillkännagivande • Jun 19
Baijin Life Science Holdings Limited to Report Fiscal Year 2026 Final Results on Jun 30, 2026 Baijin Life Science Holdings Limited announced that they will report fiscal year 2026 final results at 12:30 PM, China Standard Time on Jun 30, 2026 Tillkännagivande • Nov 17
Baijin Life Science Holdings Limited to Report First Half, 2026 Results on Nov 27, 2025 Baijin Life Science Holdings Limited announced that they will report first half, 2026 results on Nov 27, 2025 Tillkännagivande • Sep 30
Baijin Life Science Holdings Limited has filed a Follow-on Equity Offering in the amount of HKD 19.2 million. Baijin Life Science Holdings Limited has filed a Follow-on Equity Offering in the amount of HKD 19.2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 40,000,000
Price\Range: HKD 0.48
Transaction Features: Subsequent Direct Listing Tillkännagivande • Aug 21
Baijin Life Science Holdings Limited, Annual General Meeting, Sep 30, 2025 Baijin Life Science Holdings Limited, Annual General Meeting, Sep 30, 2025, at 11:00 China Standard Time. Location: unit d, 8/f, kingston international centre, 19 wang chiu road, kowloon bay, Hong Kong Tillkännagivande • Jul 15
Baijin Life Science Holdings Limited to Report Fiscal Year 2025 Final Results on Jul 25, 2025 Baijin Life Science Holdings Limited announced that they will report fiscal year 2025 final results on Jul 25, 2025 Tillkännagivande • Jun 09
Baijin Life Science Holdings Limited to Report Fiscal Year 2025 Results on Jun 30, 2025 Baijin Life Science Holdings Limited announced that they will report fiscal year 2025 results on Jun 30, 2025 Tillkännagivande • Apr 03
Baijin Life Science Holdings Limited has completed a Follow-on Equity Offering in the amount of HKD 31.372528 million. Baijin Life Science Holdings Limited has completed a Follow-on Equity Offering in the amount of HKD 31.372528 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 65,359,433
Price\Range: HKD 0.48
Transaction Features: Subsequent Direct Listing Tillkännagivande • Mar 18
Baijin Life Science Holdings Limited has filed a Follow-on Equity Offering in the amount of HKD 31.372528 million. Baijin Life Science Holdings Limited has filed a Follow-on Equity Offering in the amount of HKD 31.372528 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 65,359,433
Price\Range: HKD 0.48
Transaction Features: Subsequent Direct Listing Tillkännagivande • Nov 19
Affluent Partners Holdings Limited to Report First Half, 2025 Results on Nov 29, 2024 Affluent Partners Holdings Limited announced that they will report first half, 2025 results on Nov 29, 2024 Tillkännagivande • Aug 29
Affluent Partners Holdings Limited, Annual General Meeting, Sep 30, 2024 Affluent Partners Holdings Limited, Annual General Meeting, Sep 30, 2024, at 11:00 China Standard Time. Location: units 5906-12, 59/f, the center, 99 queen`s road central, central, Hong Kong Tillkännagivande • Jun 26
Affluent Partners Holdings Limited to Report Fiscal Year 2024 Results on Jul 19, 2024 Affluent Partners Holdings Limited announced that they will report fiscal year 2024 results at 4:00 PM, China Standard Time on Jul 19, 2024 Tillkännagivande • Mar 27
Affluent Partners Holdings Limited Announces Changes to Its Board and Committees The Board of Affluent Partners Holdings Limited announced that, with effect on 26 March 2024, Dr. Su Yaoyao has been appointed as an executive Director of the Company, one of the Authorised Representatives and Process Agent. Dr. Su, aged 41, has been the general manager of Beijing Baijing Biotechnology Company Limited since March 2022 and was the general manager of Hangzhou Qingda Kerui Biological Technology Co. Ltd. from September 2018 to March 2022. Dr. Su graduated from Southeast University with a bachelor's degree in public health and PhD degree in public health in 2006 and 2012 respectively. The Board further announced that Mr. Cheng Chi Kin ("Mr. Cheng''), the Chairman of the Board and an executive Director, has resigned from his role as Chairman and re-designated as a non-executive Director with effect from 26 March 2024, due to his other business commitments. Mr. Cheng has also resigned as a member of the Remuneration Committee and Nomination Committee of the Board, and will cease to act as one of the Authorised Representatives and the Process Agent on the same date. Mr. Cheng Chi Kin, aged 55, was appointed as an executive director and the Chairman of the Board of the Company on 27 September 2019 and 18 October 2019 respectively. He obtained a Degree in Business Studies from University of Glamorgan in 1992 and a Master Degree in Business Administration from Cardiff Business School in 1993. He is a fellow member of Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of International Accountants. He is also a Chartered Marketer of The Chartered Institute of Marketing and a member of Institute of Management Accountants. He has over 28 years of working experience in merger and acquisition, finance and accounting, banking, asset management and funds operations in various industries including real estate developments, infrastructure developments, real estate investment trusts (REITS), securities investments and natural resources industries. Mr. Cheng was an executive director and the chief executive officer of China Uptown Group Company Limited from June 2022 to March 2024, an executive director of DeTai New Energy Group Limited from August 2021 to March 2024 and the chairman of the board of the same company from November 2021 to March 2024, and the shares of both companies are listed on the Main Board of the Stock Exchange. The Board further announced that following the appointment of Dr. Su and re-designation of Mr. Cheng, both Mr. Cheung Sze Ming, an executive Director, and Dr. Su will be appointed as members of the Remuneration Committee and Nomination Committee of the Board on 26 March 2024. Tillkännagivande • Nov 29
Affluent Partners Holdings Limited Announces Appointment of Lee Ka Leung Daniel as an Independent Non-Executive Director, the Chairman of the Audit Committee, A Member of the Remuneration Committee and A Member of the Nomination Committee The board of directors of Affluent Partners Holdings Limited announced Mr. Lee Ka Leung Daniel has been appointed as an independent non-executive Director, the chairman of the Audit Committee, a member of the Remuneration Committee and a member of the Nomination Committee of the Company with effect from 29 November 2023. Mr. Lee, aged 65, is a certified public accountant with practising certificate. He is the fellow member of Hong Kong Institute of Certified Public Accountants and Association of Chartered Certified Accountants. Mr. Lee was the founder and managing partner of K. L. Lee & Partners C.P.A. Limited and KLL Associates CPA Limited which were merged with BDO Limited, Hong Kong member firm of the international accounting network BDO in 2005. Mr. Lee retired from BDO Limited as partner in 2023. Mr. Lee was a member of the Chinese People's Political Consultative Conference Hainan Committee during the period from 2013-2022. Mr. Lee was an independent non-executive director of China Credit Holdings Limited (currently named as Zensun Enterprises Limited), a company listed on The Stock Exchange of Hong Kong Limited during the period from 1994 to 2006 and China Gas Holdings Limited, a company listed on the Stock Exchange during the period from 1997 to 2003. Tillkännagivande • Nov 17
Affluent Partners Holdings Limited to Report First Half, 2024 Results on Nov 28, 2023 Affluent Partners Holdings Limited announced that they will report first half, 2024 results on Nov 28, 2023 Tillkännagivande • Oct 28
Affluent Partners Holdings Limited Appoints Dong Peng as Executive Director Affluent Partners Holdings Limited appointed Mr. Dong Peng as executive Director of the Company with effect from 27 October 2023. Mr. Dong, aged 35, occupied management roles in the fields of corporate communications and marketing in Shanghai and Shenzhen prior to joining the Company. Mr. Dong has been an investor relationship director at Shanghai Dao Zhi Information Technology Co., Limited since August 2022 and was a senior consultant of marketing department of Yunrui (Shenzhen) Information Technology Co., Limited* (()) from July 2020 to July 2022. He had served as a military officer in China for 5 years prior to working in the private sector. Tillkännagivande • Jul 29
Affluent Partners Holdings Limited, Annual General Meeting, Aug 30, 2023 Affluent Partners Holdings Limited, Annual General Meeting, Aug 30, 2023, at 11:00 China Standard Time. Location: Units 590612, 59/F, The Center, 99 Queen's Road Central, Central Hong Kong Agenda: To receive and consider the audited financial statements and the reports of the Directors and the independent auditor of the Company for the year ended 31 March 2023; to re-elect the retiring Directors; to authorise the Board of Directors to fix the Directors' remuneration; to re-appoint Moore Stephens CPA Limited as the independent auditor of the Company and to authorise the Board of Directors to fix its remuneration; and to consider other matters. Tillkännagivande • Jun 16
Affluent Partners Holdings Limited to Report Fiscal Year 2023 Results on Jun 28, 2023 Affluent Partners Holdings Limited announced that they will report fiscal year 2023 results on Jun 28, 2023 Tillkännagivande • May 11
Affluent Partners Holdings Limited Announces Resignation of Chiu Sin Nang as Independent Non-Executive Director The Board of Affluent Partners Holdings Limited announced that Mr. Chiu has tendered his resignation as an independent non-executive Director, the chairman of the Audit Committee, a member of the Nomination Committee and a member of the Remuneration Committee of the Company with effect from the date of this announcement as he intended to devote more time to his other business engagements. Mr. Chiu has confirmed that he has no disagreement with the Board and there is no matter in relation to his resignation from the position that needs to be brought to the attention of the Stock Exchange and the shareholders of the Company. 